https://abbvie.indrap.org/questions/true-or-false/2017-08-07T05:02:17+01:00https://abbvie.indrap.org/questions/multiple-choice/2017-08-07T05:02:28+01:00https://abbvie.indrap.org/questions/a/2017-08-07T05:02:35+01:00https://abbvie.indrap.org/questions/true-or-false-2/2017-08-07T05:07:44+01:00https://abbvie.indrap.org/questions/multiple-choice-2/2017-08-07T05:07:51+01:00https://abbvie.indrap.org/questions/choose-the-most-correct-answer/2017-08-07T05:08:08+01:00https://abbvie.indrap.org/questions/choose-the-most-correct-answer-copy/2017-08-07T07:45:06+01:00https://abbvie.indrap.org/questions/choose-the-most-correct-answer-copy-2/2017-08-07T07:45:07+01:00https://abbvie.indrap.org/questions/multiple-choice-copy/2017-08-07T07:45:08+01:00https://abbvie.indrap.org/questions/multiple-choice-copy-2/2017-08-07T07:45:09+01:00https://abbvie.indrap.org/questions/true-or-false-copy/2017-08-07T07:45:10+01:00https://abbvie.indrap.org/questions/true-or-false-copy-2/2017-08-07T07:45:12+01:00https://abbvie.indrap.org/questions/1-and-2-are-answers/2015-12-16T07:15:02+01:00https://abbvie.indrap.org/questions/how-do-you-add-a-background-color-for-all-elements/2015-06-05T09:27:31+01:00https://abbvie.indrap.org/questions/how-many-tags-are-in-a-regular-element-2/2015-06-05T03:18:31+01:00https://abbvie.indrap.org/questions/how-do-you-display-a-border-like-this-the-top-border-10-pixels-the-bottom-border-5-pixels-the-left-border-20-pixels-the-right-border-1pixel-2-2/2015-06-05T09:33:29+01:00https://abbvie.indrap.org/questions/how-do-you-insert-a-comment-in-a-css-file-2/2015-06-05T09:26:24+01:00https://abbvie.indrap.org/questions/in-which-directory-of-your-host-the-plugins-exist/2015-06-06T08:29:23+01:00https://abbvie.indrap.org/questions/what-does-html-stand-for-2/2015-06-05T03:17:20+01:00https://abbvie.indrap.org/questions/what-is-the-difference-in-an-opening-tag-and-a-closing-tag-2/2015-06-05T03:18:57+01:00https://abbvie.indrap.org/questions/what-type-of-tag-is-this-2/2015-06-05T03:19:48+01:00https://abbvie.indrap.org/questions/is-this-an-opening-tag-or-a-closing-tag-3/2015-06-05T03:20:30+01:00https://abbvie.indrap.org/questions/is-this-an-opening-tag-or-a-closing-tag-2-2/2015-06-05T03:21:11+01:00https://abbvie.indrap.org/questions/where-is-the-meta-tag-only-found-2/2015-06-05T03:25:16+01:00https://abbvie.indrap.org/questions/what-is-an-element-that-does-not-having-a-closing-tag-called-2/2015-06-05T03:26:35+01:00https://abbvie.indrap.org/questions/which-of-the-following-is-an-example-of-an-empty-element-2/2015-06-05T03:27:10+01:00https://abbvie.indrap.org/questions/what-should-values-always-be-enclosed-in-2/2015-06-05T03:27:50+01:00https://abbvie.indrap.org/questions/where-do-all-items-for-the-same-web-site-need-to-be-saved-2/2015-06-05T03:28:53+01:00https://abbvie.indrap.org/questions/what-does-g-o-o-g-l-e-do-2/2015-06-05T03:29:28+01:00https://abbvie.indrap.org/questions/what-is-always-a-welcome-page-and-explains-the-purpose-or-topic-of-the-site-2/2015-06-05T03:31:59+01:00https://abbvie.indrap.org/questions/what-does-view-source-do-2/2015-06-05T03:32:35+01:00https://abbvie.indrap.org/questions/which-html-attribute-specifies-an-alternate-text-for-an-image-if-the-image-cannot-be-displayed-2/2015-06-05T03:34:30+01:00https://abbvie.indrap.org/questions/11-2/2017-08-09T05:55:29+01:00https://abbvie.indrap.org/questions/22-2/2017-08-09T05:55:41+01:00https://abbvie.indrap.org/questions/33-2/2017-08-09T05:55:52+01:00https://abbvie.indrap.org/questions/hgf/2018-05-31T10:40:16+01:00https://abbvie.indrap.org/questions/1-the-cut-off-mark-for-viral-suppression-in-a-person-living-with-hiv-is-_____________copies-per-ml/2021-05-19T00:13:15+01:00https://abbvie.indrap.org/questions/2-cryptococcal-meningitis-requires-pre-emptive-therapy-in-patients-with-advance-hiv-disease/2021-05-19T00:16:03+01:00https://abbvie.indrap.org/questions/3-abc-3tc-lpvr-is-the-preferred-1st-line-regimen-for-children-0-3-years-on-art-in-nigeria/2021-05-19T00:16:29+01:00https://abbvie.indrap.org/questions/4-dtg-can-be-considered-as-both-1st-and-2nd-line-option-in-anti-retroviral-treatment-in-nigeria/2021-05-19T00:16:56+01:00https://abbvie.indrap.org/questions/5-which-one-of-these-is-not-an-antiretroviral-drug-class-in-use-in-nigeria/2021-05-19T00:17:16+01:00https://abbvie.indrap.org/questions/tb-co-infection-is-a-who-stage-1-condition/2021-05-19T00:18:42+01:00https://abbvie.indrap.org/questions/7-first-line-regimen-for-a-8kg-child-is/2021-05-19T00:19:04+01:00https://abbvie.indrap.org/questions/ebele-has-been-on-treatment-for-5-years-on-her-last-appointment-she-complained-about-her-inability-to-get-time-off-work-for-her-monthly-checkups-her-last-viral-load-result-was-suppressed-which-of-t/2021-05-19T00:20:34+01:00https://abbvie.indrap.org/questions/according-to-the-nigeria-art-guidelines-which-of-these-is-the-current-criteria-for-commencing-arvs/2021-05-19T00:22:16+01:00https://abbvie.indrap.org/questions/all-of-the-below-are-true-about-the-global-impact-of-hiv-except/2021-05-19T00:23:25+01:00https://abbvie.indrap.org/questions/which-of-the-following-is-not-recommended-as-hiv-testing-services-strategies-in-nigeria/2021-05-19T00:32:55+01:00https://abbvie.indrap.org/questions/dtg-is-now-an-approved-drug-for-the-treatment-of-hiv-in-children-of-all-ages-in-nigeria/2021-05-19T00:35:19+01:00https://abbvie.indrap.org/questions/the-cut-off-mark-for-viral-suppression-in-a-person-living-with-hiv-is-_____________copies-per-ml-copy/2021-05-28T10:34:11+01:00https://abbvie.indrap.org/questions/cryptococcal-meningitis-requires-pre-emptive-therapy-in-patients-with-advance-hiv-disease-copy/2021-05-28T10:34:33+01:00https://abbvie.indrap.org/questions/abc-3tc-lpvr-is-the-preferred-1st-line-regimen-for-children-0-3-years-on-art-in-nigeria-copy/2021-05-28T10:35:04+01:00https://abbvie.indrap.org/questions/dtg-can-be-considered-as-both-1st-and-2nd-line-option-in-anti-retroviral-treatment-in-nigeria-copy/2021-05-28T10:35:14+01:00https://abbvie.indrap.org/questions/which-one-of-these-is-not-an-antiretroviral-drug-class-in-use-in-nigeria-copy/2021-05-28T10:36:03+01:00https://abbvie.indrap.org/questions/tb-co-infection-is-a-who-stage-1-condition-copy/2021-05-28T10:36:11+01:00https://abbvie.indrap.org/questions/first-line-regimen-for-a-8kg-child-is-copy/2021-05-28T10:36:21+01:00https://abbvie.indrap.org/questions/ebele-has-been-on-treatment-for-5-years-on-her-last-appointment-she-complained-about-her-inability-to-get-time-off-work-for-her-monthly-checkups-her-last-viral-load-result-was-suppressed-which-of-t-2/2021-05-28T10:36:30+01:00https://abbvie.indrap.org/questions/according-to-the-nigeria-art-guidelines-which-of-these-is-the-current-criteria-for-commencing-arvs-copy/2021-05-28T10:36:46+01:00https://abbvie.indrap.org/questions/all-of-the-below-are-true-about-the-global-impact-of-hiv-except-copy/2021-05-28T10:36:58+01:00https://abbvie.indrap.org/questions/according-to-2018-naiis-the-prevalence-of-hiv-aid-among-children-0-14-years-is/2021-12-16T13:47:37+01:00https://abbvie.indrap.org/questions/the-recommended-diagnostic-modalities-for-children-less-than-18-month-is/2021-12-16T13:49:09+01:00https://abbvie.indrap.org/questions/as-part-of-the-flow-up-for-hiv-exposed-infants/2021-12-16T13:50:07+01:00https://abbvie.indrap.org/questions/children-and-adolescent-are-considered-to-be-on-optimized-regimen-when-all-but-one-of-the-following-occur/2021-12-16T13:51:34+01:00https://abbvie.indrap.org/questions/adolescent-friendly-services-includes-all-but-one-of-the-following/2021-12-16T13:52:50+01:00https://abbvie.indrap.org/questions/adolescent-friendly-minimum-package-of-care-includes/2021-12-16T13:54:04+01:00https://abbvie.indrap.org/questions/one-of-the-following-is-not-consider-a-major-challenge-that-could-impact-best-outcome-of-pediatrics-art/2021-12-16T13:54:54+01:00https://abbvie.indrap.org/questions/social-experiences-that-can-lead-to-psychological-problems-includes-select-all-that-applies/2021-12-16T13:55:54+01:00https://abbvie.indrap.org/questions/the-following-are-causes-of-psychosocial-problems-in-hiv-affected-children-select-all-that-applies/2021-12-16T13:57:07+01:00https://abbvie.indrap.org/questions/stigma-may-be-defined-as/2021-12-16T14:30:51+01:00https://abbvie.indrap.org/questions/stigma-discrimination-could-be-expressed-as-select-all-that-applies/2021-12-16T14:52:45+01:00https://abbvie.indrap.org/questions/psychosocial-impact-of-hiv-in-children-may-manifest-as-select-all-that-applies/2021-12-16T14:53:29+01:00https://abbvie.indrap.org/questions/psycho-social-assessment-of-children-living-with-hiv-should-be-carried-out-at/2021-12-16T14:54:23+01:00https://abbvie.indrap.org/questions/types-and-levels-of-psychological-and-social-intervention-includes-select-all-that-applies/2021-12-16T14:55:09+01:00https://abbvie.indrap.org/questions/reasons-for-community-based-adherence-includes/2021-12-16T14:55:55+01:00https://abbvie.indrap.org/questions/all-but-one-of-the-following-services-can-be-provided-in-the-community/2021-12-16T14:56:48+01:00https://abbvie.indrap.org/questions/the-following-are-stages-of-community-based-adherence-activities-select-all-that-applies/2021-12-16T14:58:34+01:00https://abbvie.indrap.org/questions/all-exposed-babies-who-are-breastfeeding-should-get-at-least-3-dna-pcr-tests-birth-6-weeks-and-6-weeks-after-cessation-of-breastfeeding/2021-12-16T14:59:33+01:00https://abbvie.indrap.org/questions/psycho-social-can-mean-the-dynamic-relationship-between-social-and-psychological-experiences-where-the-effects-of-one-does-not-influence-the-other/2021-12-16T14:59:45+01:00https://abbvie.indrap.org/questions/community-based-adherence-activities-transcends-the-entire-continuum-of-care-for-hiv-patients/2021-12-16T15:00:02+01:00https://abbvie.indrap.org/questions/according-to-2018-naiis-the-prevalence-of-hiv-aid-among-children-0-14-years-is-copy/2021-12-19T14:30:40+01:00https://abbvie.indrap.org/questions/the-recommended-diagnostic-modalities-for-children-less-than-18-month-is-copy/2021-12-19T14:30:47+01:00https://abbvie.indrap.org/questions/as-part-of-the-flow-up-for-hiv-exposed-infants-copy/2021-12-19T14:30:51+01:00https://abbvie.indrap.org/questions/children-and-adolescent-are-considered-to-be-on-optimized-regimen-when-all-but-one-of-the-following-occur-copy/2021-12-19T14:30:59+01:00https://abbvie.indrap.org/questions/adolescent-friendly-services-includes-all-but-one-of-the-following-copy/2021-12-19T14:31:06+01:00https://abbvie.indrap.org/questions/adolescent-friendly-minimum-package-of-care-includes-copy/2021-12-19T14:31:12+01:00https://abbvie.indrap.org/questions/one-of-the-following-is-not-consider-a-major-challenge-that-could-impact-best-outcome-of-pediatrics-art-copy/2021-12-19T14:31:20+01:00https://abbvie.indrap.org/questions/social-experiences-that-can-lead-to-psychological-problems-includes-select-all-that-applies-copy/2021-12-19T14:31:26+01:00https://abbvie.indrap.org/questions/the-following-are-causes-of-psychosocial-problems-in-hiv-affected-children-select-all-that-applies-copy/2021-12-19T14:31:33+01:00https://abbvie.indrap.org/questions/stigma-may-be-defined-as-copy/2021-12-19T14:31:36+01:00https://abbvie.indrap.org/questions/stigma-discrimination-could-be-expressed-as-select-all-that-applies-copy/2021-12-19T14:31:48+01:00https://abbvie.indrap.org/questions/psychosocial-impact-of-hiv-in-children-may-manifest-as-select-all-that-applies-copy/2021-12-19T14:31:55+01:00https://abbvie.indrap.org/questions/psycho-social-assessment-of-children-living-with-hiv-should-be-carried-out-at-copy/2021-12-19T14:32:07+01:00https://abbvie.indrap.org/questions/types-and-levels-of-psychological-and-social-intervention-includes-select-all-that-applies-copy/2021-12-19T14:32:21+01:00https://abbvie.indrap.org/questions/reasons-for-community-based-adherence-includes-copy/2021-12-19T14:32:27+01:00https://abbvie.indrap.org/questions/all-but-one-of-the-following-services-can-be-provided-in-the-community-copy/2021-12-19T14:32:33+01:00https://abbvie.indrap.org/questions/the-following-are-stages-of-community-based-adherence-activities-select-all-that-applies-copy/2021-12-19T14:32:41+01:00https://abbvie.indrap.org/questions/all-exposed-babies-who-are-breastfeeding-should-get-at-least-3-dna-pcr-tests-birth-6-weeks-and-6-weeks-after-cessation-of-breastfeeding-copy/2021-12-19T14:32:52+01:00https://abbvie.indrap.org/questions/psycho-social-can-mean-the-dynamic-relationship-between-social-and-psychological-experiences-where-the-effects-of-one-does-not-influence-the-other-copy/2021-12-19T14:33:04+01:00https://abbvie.indrap.org/questions/community-based-adherence-activities-transcends-the-entire-continuum-of-care-for-hiv-patients-copy/2021-12-19T14:33:12+01:00https://abbvie.indrap.org/questions/the-following-are-principles-of-anti-retroviral-therapy-except/2021-05-09T08:26:28+01:00https://abbvie.indrap.org/questions/the-following-are-possible-complications-of-nevirapine-toxicity/2021-05-09T08:40:14+01:00https://abbvie.indrap.org/questions/which-of-the-following-best-defines-differentiated-care-model/2021-05-09T09:58:52+01:00https://abbvie.indrap.org/questions/which-of-the-following-is-not-an-advantage-of-differentiated-care-model/2021-05-12T13:25:32+01:00https://abbvie.indrap.org/questions/inclusion-criteria-for-differentiated-care-model-will-include-all-of-the-following-except/2021-05-12T13:28:00+01:00https://abbvie.indrap.org/questions/what-is-resistance/2021-05-12T13:29:09+01:00https://abbvie.indrap.org/questions/regarding-treatment-failure-when-a-patient-fails-nevirapine-he-can-be-switched-to-an-efavirenz-based-regimen/2021-05-12T13:30:11+01:00https://abbvie.indrap.org/questions/timeline-for-viral-load-sample-collection-include-the-following-except/2021-05-12T13:30:55+01:00https://abbvie.indrap.org/questions/k103n-is-selected-by/2021-05-12T13:32:20+01:00https://abbvie.indrap.org/questions/the-following-are-true-of-third-line-regimen-except/2021-05-12T13:33:15+01:00https://abbvie.indrap.org/questions/the-following-are-principles-of-anti-retroviral-therapy-except-copy/2021-05-10T17:43:56+01:00https://abbvie.indrap.org/questions/the-following-are-possible-complications-of-nevirapine-toxicity-copy/2021-05-10T17:43:56+01:00https://abbvie.indrap.org/questions/which-of-the-following-best-defines-differentiated-care-model-copy/2021-05-10T17:43:56+01:00https://abbvie.indrap.org/questions/the-following-are-principles-of-anti-retroviral-therapy-except-2/2021-05-09T08:26:28+01:00https://abbvie.indrap.org/questions/the-following-are-possible-complications-of-nevirapine-toxicity-2/2021-05-09T08:40:14+01:00https://abbvie.indrap.org/questions/which-of-the-following-best-defines-differentiated-care-model-2/2021-05-09T09:58:52+01:00https://abbvie.indrap.org/questions/which-of-the-following-is-not-an-advantage-of-differentiated-care-model-2/2021-05-12T13:25:32+01:00https://abbvie.indrap.org/questions/inclusion-criteria-for-differentiated-care-model-will-include-all-of-the-following-except-2/2021-05-12T13:28:00+01:00https://abbvie.indrap.org/questions/what-is-resistance-2/2021-05-12T13:29:09+01:00https://abbvie.indrap.org/questions/regarding-treatment-failure-when-a-patient-fails-nevirapine-he-can-be-switched-to-an-efavirenz-based-regimen-2/2021-05-12T13:30:11+01:00https://abbvie.indrap.org/questions/timeline-for-viral-load-sample-collection-include-the-following-except-2/2021-05-12T13:30:55+01:00https://abbvie.indrap.org/questions/k103n-is-selected-by-2/2021-05-12T13:32:20+01:00https://abbvie.indrap.org/questions/the-following-are-true-of-third-line-regimen-except-2/2021-05-12T13:33:15+01:00https://abbvie.indrap.org/questions/the-following-are-principles-of-anti-retroviral-therapy-except-copy-2/2021-05-10T17:43:56+01:00https://abbvie.indrap.org/questions/the-following-are-possible-complications-of-nevirapine-toxicity-copy-2/2021-05-10T17:43:56+01:00https://abbvie.indrap.org/questions/which-of-the-following-best-defines-differentiated-care-model-copy-2/2021-05-10T17:43:56+01:00https://abbvie.indrap.org/questions/all-of-the-below-are-true-about-the-global-impact-of-hiv-except-copy-2/2021-05-28T10:36:58+01:00https://abbvie.indrap.org/questions/all-of-the-below-are-true-about-the-global-impact-of-hiv-except-copy-3/2021-05-28T10:36:58+01:00https://abbvie.indrap.org/questions/1-the-cut-off-mark-for-viral-suppression-in-a-person-living-with-hiv-is-_____________copies-per-ml-2/2021-05-19T00:13:15+01:00https://abbvie.indrap.org/questions/2-cryptococcal-meningitis-requires-pre-emptive-therapy-in-patients-with-advance-hiv-disease-2/2021-05-19T00:16:03+01:00https://abbvie.indrap.org/questions/3-abc-3tc-lpvr-is-the-preferred-1st-line-regimen-for-children-0-3-years-on-art-in-nigeria-2/2021-05-19T00:16:29+01:00https://abbvie.indrap.org/questions/4-dtg-can-be-considered-as-both-1st-and-2nd-line-option-in-anti-retroviral-treatment-in-nigeria-2/2021-05-19T00:16:56+01:00https://abbvie.indrap.org/questions/5-which-one-of-these-is-not-an-antiretroviral-drug-class-in-use-in-nigeria-2/2021-05-19T00:17:16+01:00https://abbvie.indrap.org/questions/tb-co-infection-is-a-who-stage-1-condition-2/2021-05-19T00:18:42+01:00https://abbvie.indrap.org/questions/7-first-line-regimen-for-a-8kg-child-is-2/2021-05-19T00:19:04+01:00https://abbvie.indrap.org/questions/ebele-has-been-on-treatment-for-5-years-on-her-last-appointment-she-complained-about-her-inability-to-get-time-off-work-for-her-monthly-checkups-her-last-viral-load-result-was-suppressed-which-of-t-3/2021-05-19T00:20:34+01:00https://abbvie.indrap.org/questions/according-to-the-nigeria-art-guidelines-which-of-these-is-the-current-criteria-for-commencing-arvs-2/2021-05-19T00:22:16+01:00https://abbvie.indrap.org/questions/all-of-the-below-are-true-about-the-global-impact-of-hiv-except-2/2021-05-19T00:23:25+01:00https://abbvie.indrap.org/questions/which-of-the-following-is-not-recommended-as-hiv-testing-services-strategies-in-nigeria-2/2021-05-19T00:32:55+01:00https://abbvie.indrap.org/questions/dtg-is-now-an-approved-drug-for-the-treatment-of-hiv-in-children-of-all-ages-in-nigeria-2/2021-05-19T00:35:19+01:00https://abbvie.indrap.org/questions/the-cut-off-mark-for-viral-suppression-in-a-person-living-with-hiv-is-_____________copies-per-ml-copy-2/2021-05-28T10:34:11+01:00https://abbvie.indrap.org/questions/cryptococcal-meningitis-requires-pre-emptive-therapy-in-patients-with-advance-hiv-disease-copy-2/2021-05-28T10:34:33+01:00https://abbvie.indrap.org/questions/abc-3tc-lpvr-is-the-preferred-1st-line-regimen-for-children-0-3-years-on-art-in-nigeria-copy-2/2021-05-28T10:35:04+01:00https://abbvie.indrap.org/questions/dtg-can-be-considered-as-both-1st-and-2nd-line-option-in-anti-retroviral-treatment-in-nigeria-copy-2/2021-05-28T10:35:14+01:00https://abbvie.indrap.org/questions/which-one-of-these-is-not-an-antiretroviral-drug-class-in-use-in-nigeria-copy-2/2021-05-28T10:36:03+01:00https://abbvie.indrap.org/questions/tb-co-infection-is-a-who-stage-1-condition-copy-2/2021-05-28T10:36:11+01:00https://abbvie.indrap.org/questions/first-line-regimen-for-a-8kg-child-is-copy-2/2021-05-28T10:36:21+01:00https://abbvie.indrap.org/questions/ebele-has-been-on-treatment-for-5-years-on-her-last-appointment-she-complained-about-her-inability-to-get-time-off-work-for-her-monthly-checkups-her-last-viral-load-result-was-suppressed-which-of-t-4/2021-05-28T10:36:30+01:00https://abbvie.indrap.org/questions/according-to-the-nigeria-art-guidelines-which-of-these-is-the-current-criteria-for-commencing-arvs-copy-2/2021-05-28T10:36:46+01:00https://abbvie.indrap.org/questions/all-of-the-below-are-true-about-the-global-impact-of-hiv-except-copy-4/2021-05-28T10:36:58+01:00https://abbvie.indrap.org/questions/which-of-the-following-is-a-problem-associated-with-economic-planning-in-nigeria/2022-01-13T12:40:39+01:00https://abbvie.indrap.org/questions/the-cut-off-mark-for-viral-suppression-in-a-person-living-with-hiv-is-_____________copies-per-ml/2024-08-08T17:31:39+01:00https://abbvie.indrap.org/questions/cryptococcal-meningitis-requires-pre-emptive-therapy-in-patients-with-advance-hiv-disease/2024-08-08T17:33:53+01:00https://abbvie.indrap.org/questions/abc-3tc-lpvr-is-the-preferred-1st-line-regimen-for-children-0-3-years-on-art-in-nigeria/2024-08-08T17:34:40+01:00https://abbvie.indrap.org/questions/dtg-can-be-considered-as-both-1st-and-2nd-line-option-in-anti-retroviral-treatment-in-nigeria/2024-08-08T17:34:56+01:00https://abbvie.indrap.org/questions/which-one-of-these-is-not-an-antiretroviral-drug-class-in-use-in-nigeria/2024-08-08T17:35:22+01:00https://abbvie.indrap.org/questions/tb-co-infection-is-a-who-stage-1-condition-3/2024-08-08T17:37:09+01:00https://abbvie.indrap.org/questions/first-line-regimen-for-a-8kg-child-is/2024-08-08T17:37:38+01:00https://abbvie.indrap.org/questions/ebele-has-been-on-treatment-for-5-years-on-her-last-appointment-she-complained-about-her-inability-to-get-time-off-work-for-her-monthly-checkups-her-last-viral-load-result-was-suppressed-which-of-t-5/2024-08-08T17:39:38+01:00https://abbvie.indrap.org/questions/according-to-the-nigeria-art-guidelines-which-of-these-is-the-current-criteria-for-commencing-arvs-3/2024-08-08T17:47:19+01:00https://abbvie.indrap.org/questions/all-of-the-below-are-true-about-the-global-impact-of-hiv-except-3/2024-08-08T17:50:38+01:00https://abbvie.indrap.org/questions/which-of-the-following-is-not-recommended-as-hiv-testing-services-strategies-in-nigeria-3/2024-08-08T17:56:50+01:00https://abbvie.indrap.org/questions/dtg-is-now-an-approved-drug-for-the-treatment-of-hiv-in-children-of-all-ages-in-nigeria-3/2024-08-08T17:58:51+01:00https://abbvie.indrap.org/questions/according-to-2018-naiis-the-prevalence-of-hiv-aid-among-children-0-14-years-iscopy/2024-08-09T16:32:44+01:00https://abbvie.indrap.org/questions/the-recommended-diagnostic-modalities-for-children-less-than-18-month-iscopy/2024-08-09T16:32:44+01:00https://abbvie.indrap.org/questions/as-part-of-the-flow-up-for-hiv-exposed-infantscopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/children-and-adolescent-are-considered-to-be-on-optimized-regimen-when-all-but-one-of-the-following-occurcopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/adolescent-friendly-services-includes-all-but-one-of-the-followingcopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/adolescent-friendly-minimum-package-of-care-includescopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/one-of-the-following-is-not-consider-a-major-challenge-that-could-impact-best-outcome-of-pediatrics-artcopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/social-experiences-that-can-lead-to-psychological-problems-includes-select-all-that-appliescopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/the-following-are-causes-of-psychosocial-problems-in-hiv-affected-children-select-all-that-appliescopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/stigma-may-be-defined-ascopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/stigma-discrimination-could-be-expressed-as-select-all-that-appliescopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/psychosocial-impact-of-hiv-in-children-may-manifest-as-select-all-that-appliescopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/psycho-social-assessment-of-children-living-with-hiv-should-be-carried-out-atcopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/types-and-levels-of-psychological-and-social-intervention-includes-select-all-that-appliescopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/reasons-for-community-based-adherence-includescopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/all-but-one-of-the-following-services-can-be-provided-in-the-communitycopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/the-following-are-stages-of-community-based-adherence-activities-select-all-that-appliescopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/all-exposed-babies-who-are-breastfeeding-should-get-at-least-3-dna-pcr-tests-birth-6-weeks-and-6-weeks-after-cessation-of-breastfeedingcopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/psycho-social-can-mean-the-dynamic-relationship-between-social-and-psychological-experiences-where-the-effects-of-one-does-not-influence-the-othercopy/2024-08-09T16:32:45+01:00https://abbvie.indrap.org/questions/community-based-adherence-activities-transcends-the-entire-continuum-of-care-for-hiv-patientscopy/2024-08-09T16:32:46+01:00https://abbvie.indrap.org/questions/the-cut-off-mark-for-viral-suppression-in-a-person-living-with-hiv-is-_____________copies-per-ml-copy-3/2024-08-09T16:35:16+01:00https://abbvie.indrap.org/questions/cryptococcal-meningitis-requires-pre-emptive-therapy-in-patients-with-advance-hiv-diseasecopy/2024-08-09T16:35:25+01:00https://abbvie.indrap.org/questions/abc-3tc-lpvr-is-the-preferred-1st-line-regimen-for-children-0-3-years-on-art-in-nigeria-copy-3/2024-08-09T16:35:18+01:00https://abbvie.indrap.org/questions/dtg-can-be-considered-as-both-1st-and-2nd-line-option-in-anti-retroviral-treatment-in-nigeriacopy/2024-08-09T16:35:28+01:00https://abbvie.indrap.org/questions/which-one-of-these-is-not-an-antiretroviral-drug-class-in-use-in-nigeriacopy/2024-08-09T16:35:32+01:00https://abbvie.indrap.org/questions/tb-co-infection-is-a-who-stage-1-conditioncopy/2024-08-09T16:35:37+01:00https://abbvie.indrap.org/questions/first-line-regimen-for-a-8kg-child-iscopy/2024-08-09T16:35:38+01:00https://abbvie.indrap.org/questions/ebele-has-been-on-treatment-for-5-years-on-her-last-appointment-she-complained-about-her-inability-to-get-time-off-work-for-her-monthly-checkups-her-last-viral-load-result-was-suppressed-which-of-t-6/2024-08-09T16:35:41+01:00https://abbvie.indrap.org/questions/according-to-the-nigeria-art-guidelines-which-of-these-is-the-current-criteria-for-commencing-arvscopy/2024-08-09T16:35:43+01:00https://abbvie.indrap.org/questions/all-of-the-below-are-true-about-the-global-impact-of-hiv-exceptcopy/2024-08-09T16:35:47+01:00